John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, discusses management challenges still facing providers treating multiple myeloma.
John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, discusses management challenges still facing providers treating multiple myeloma.
Transcript
While the multiple myeloma treatment landscape has improved, what are the biggest management challenges providers treating the diseases still face?
In the las half a decade, there have been 5 or 6 drugs that have been approved for multiple myeloma and even more combinations of drugs, and in this day and era, we have more and more options available to patients, but we don’t understand how to best use those options. We need more information about the role of transplant is, especially in an era where we have very high MRD [minimal residual disease]- negativity.
We need more information about the duration of treatment, especially when you’re MRD negative, because these drugs could be used for the rest of one’s life, and if there’s no added value and there’s accumulated toxicity or increased risk of cardiopulmonary toxicity or increased risk of cancer, patients need to weigh those and physicians need to weigh those. In the absence of information, how long do you treat patients? We’re operating in the dark. So, I think those are some of the areas: what’s the role of transplant, what’s the role of multiple drug combinations, the relative benefits, and then how long do we need to treat people who have a very good response?
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More